Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Foshan Dezhong Pharmaceutical Co., Ltd., often referred to in academic literature as Dezong Pharmaceutical, is a prominent Chinese pharmaceutical company specializing in modern Traditional Chinese Medicine (TCM). Founded in 1957 and based in Foshan, Guangdong, the company is a key subsidiary of China National Traditional Chinese Medicine Holdings (China TCM), which is part of the Sinopharm Group. Dezhong is best known for its flagship product, Biyankang Tablets, a widely used treatment for allergic and chronic rhinitis that combines herbal extracts with antihistamines. The company's extensive portfolio also includes herbal plasters for pain relief, therapeutic teas, and immune-supporting granules like Yupingfeng. Operating GMP-certified facilities, Dezhong is a leader in the digitalization and standardization of TCM quality and holds the prestigious "Famous Trademark of China" designation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dezong Pharmaceutical.